Showing results (581-590 of 622) with videos related to

Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 studyMiguel Martín, Amparo Ruiz, Manuel Ruiz Borrego, et al.
Nature Reviews. Microbiology|November 20, 2021
Ecology, evolution and spillover of coronaviruses from batsManuel Ruiz-Aravena, Clifton McKee, Amandine Gamble, et al.
Clinical Rheumatology|June 23, 2018
Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort studyManuel Rubio-Rivas, Xavier Corbella, Melany Pestaña-Fernández, et al.
Current Cancer Drug Targets|August 18, 2015
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient ProfileAntonio González-Martín, Emilio Alba, Eva Ciruelos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast CancerMiguel Martín, Angel L Guerrero-Zotano, María E Pérez-López, et al.
Clinical and Experimental Rheumatology|October 6, 2017
Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosisNerea Iniesta Arandia, Carmen Pilar Simeón-Aznar, Alfredo Guillén Del Castillo, et al.
BMC Medical Genomics|October 6, 2012
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markersRoy R L Bastien, Álvaro Rodríguez-Lescure, Mark T W Ebbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2022
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical TrialRocío Montejano, Fernando de la Calle-Prieto, María Velasco, et al.
JCO Precision Oncology|July 9, 2025
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL TrialYash N Agrawal, Aranzazu Fernández-Martínez, Miguel Gil-Gil, et al.
Autoimmunity Reviews|June 1, 2017
Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohortLuis Trapiella-Martínez, José Bernardino Díaz-López, Luis Caminal-Montero, et al.
Pageof 63